NCT01841840

Brief Summary

Stroke is the third leading cause of death in the United States. Of those who are affected by stroke, a third becomes permanently disabled. Risk factors for stroke include, but are not limited to, advancing age, physical inactivity, arterial stiffness, and most commonly, high blood pressure. Stroke is a major form of a much boarder problem, cardiovascular disease (CVD). CVD is considered the primary cause of death in the US. Interestingly, increased arterial stiffness of elastic arteries (carotid and aorta) has been shown to be strongly correlated to CVD and stroke. Increased arterial stiffness is considered an independent risk for the development of CVD and stroke. Hence, arterial stiffness has been suggested as a potential therapeutic target for CVD and more specifically stroke. Recently, whole-body vibration (WBV) exercise has been proposed as a new and effective method to improve muscle mass and muscle strength in younger and older individuals. It is known that systemic arterial stiffness decreased 40 min after a single WBV session in healthy men. In our laboratory, we have shown that leg arterial stiffness decreases after a session of WBV. Taken together, this data seems to suggest WBV may be used as a viable way to decrease arterial stiffness. Special populations, such as post-stroke patients, may be unwilling or unable to perform WBV exercise so an inactive form of exercise (vibration) therapy is needed. Passive vibration (PV), allows patients to lie in an inactive, supine position, with their legs placed onto the vibration plate. This exposes the lower limbs to continuous vibration without performing voluntary muscle contraction. PV has been shown to increase skin blood flow on the vibrated extremity through vasodilation in healthy individuals and type 2 diabetics. Previous work in our laboratory has demonstrated that a 10-min session of PV on the legs decreases augmentation index (AIx) , a marker of pressure wave reflection, as well as leg and systemic PWV through decreases in local peripheral resistance in young men. However, the effects of PV on arterial function in post-stroke patients are unknown. It is hypothesized that post-stroke patients will demonstrate a decrease in leg PWV and central AIx. However, greater responses are expected with the lower vibration frequency.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
11

participants targeted

Target at below P25 for not_applicable stroke

Timeline
Completed

Started Jan 2012

Shorter than P25 for not_applicable stroke

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2012

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2012

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

April 23, 2013

Completed
6 days until next milestone

First Posted

Study publicly available on registry

April 29, 2013

Completed
Last Updated

April 29, 2013

Status Verified

April 1, 2013

Enrollment Period

6 months

First QC Date

April 23, 2013

Last Update Submit

April 24, 2013

Conditions

Keywords

StrokeHemipareticPassive VibrationArterial StiffnessPulse Wave VelocityWave ReflectionBody CompositionAutonomic Function

Outcome Measures

Primary Outcomes (3)

  • Blood Pressures

    Non-invasive measures of brachial blood pressure

    30 minutes

  • Arterial Stiffness

    Using pulse wave velocity of the aorta, systemic, and legs

    30 minutes

  • Pressure Wave Reflection

    Using the augmentation index from radial tonometry

    30 minutes

Secondary Outcomes (2)

  • Body Composition

    30 minutes

  • Autonomic Function

    30 minutes

Study Arms (3)

Control

NO INTERVENTION

This arm involves not implementing any form of intervention (passive vibration)on the subject during this visit.

Low-Frequency Pasive Vibration

EXPERIMENTAL

This arm involves exposing the subject to a 10 minute session of passive vibration set to a frequency of 25Hz and a high amplitude.

Other: Low-Frequency Passive Vibration

High-Frequency Passive Vibration

EXPERIMENTAL

This arm involves exposing the subject to a 10 minute session of passive vibration set to a frequency of 40Hz and a low amplitude.

Other: High-Frequency Pasive Vibration

Interventions

10 minute session of passive vibration set to a frequency of 25Hz and a high amplitude exposed to the legs

Also known as: Power Plate Pro5 AIRdaptive
Low-Frequency Pasive Vibration

10 minute session of passive vibration set to a frequency of 40Hz and a low amplitude exposed to the legs

Also known as: Power Plate Pro5 AIRdaptive
High-Frequency Passive Vibration

Eligibility Criteria

Age40 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years of age
  • Resting Blood Pressure between 120/80 and 159/99
  • Non-Smoker
  • Sedentary or low activity (\<120 min per week)
  • kg/m2 BMI
  • Diagnosed with stroke for at least 4 months

You may not qualify if:

  • Younger than 40 and older than 80 years of age
  • Resting Blood Pressure below 120/80 or above 159/99
  • Smoker
  • Physically active
  • BMI below 25 kg/m2 or above 39.9 kg/m2
  • Diagnosed with stroke for less than 4 months
  • Diagnosed with any other cardiovascular diseases besides stroke and stage-1 hypertension

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Florida State University

Tallahassee, Florida, 32306, United States

Location

MeSH Terms

Conditions

StrokeParesisPrehypertensionHypertension

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Arturo Figueroa, M.D., Ph.D

    Florida State University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

April 23, 2013

First Posted

April 29, 2013

Study Start

January 1, 2012

Primary Completion

July 1, 2012

Study Completion

July 1, 2012

Last Updated

April 29, 2013

Record last verified: 2013-04

Locations